Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Truist Securities Downgrades Maxar Technologies to Hold, Announces $53 Price Target

Truist Securities analyst Michael Ciarmoli downgrades Maxar Technologies (NYSE:MAXR) from Buy to Hold and announces $53 price target.

byBenzinga Newsdesk

December 16, 2022

1 minute read

Truist Securities analyst Michael Ciarmoli downgrades Maxar Technologies (NYSE:MAXR) from Buy to Hold and announces $53 price target.

EVgo Partners With WinCo Foods For EV Charging Stations

By Shivani Kumaresan

Today, 6:11 AM

EVgo Inc (NASDAQ:EVGO) has partnered with WinCo Foods to establish EV charging stations. The parties launched the first EVgo public fast charging station…

EVGO

Alibaba, JD And Tencent Lead Hang Seng Lower As New US Sanctions Weigh; Nio Rivals Xpeng, Li Auto Also Dip

By Madhukumar Warrier

Today, 6:11 AM

Shares of Alibaba Group Holding Limited (NYSE: BABA), JD.Com Inc. (NASDAQ: JD), Tencent Holdings Inc.

BABA

Tigress Financial Maintains Buy on McDonald’s, Raises Price Target to $330

By Benzinga Newsdesk

Today, 6:11 AM

Tigress Financial analyst Ivan Feinseth maintains McDonald's (NYSE:MCD) with a Buy and raises the price target from $320 to $330.

MCD

News

Intuity Medical And Embecta Launch Commercial Collaboration, Expanding Access To Self-management Innovations For People With Diabetes

By Benzinga Newsdesk

Today, 6:11 AM

Intuity Medical, Inc. and Embecta Corp. (“embecta”) (NASDAQ:EMBC) today announced they have signed a co-promotional agreement under which embecta sales representatives will be able to promote Intuity

EMBC

Truist Securities Downgrades Maxar Technologies to Hold, Announces $53 Price Target

Related Posts

EVgo Partners With WinCo Foods For EV Charging Stations

Alibaba, JD And Tencent Lead Hang Seng Lower As New US Sanctions Weigh; Nio Rivals Xpeng, Li Auto Also Dip

Tigress Financial Maintains Buy on McDonald’s, Raises Price Target to $330

Intuity Medical And Embecta Launch Commercial Collaboration, Expanding Access To Self-management Innovations For People With Diabetes